DSM entered into a collaboration with PBC Biomed to jointly design and develop materials for medical devices. Initially, the agreement will focus on the development of bone adhesives through PBC Biomed's affiliate, Biomimetic Innovations, to help meet the need for safer, less invasive surgical procedures that are also cost-effective.
DSM and PBC Biomed will develop Biomimetic Innovations' proof-of-concept for regenerative bone adhesives which support shorter operation times, lower infection rates and better healing outcomes for patients.
Marc Hendriks, Senior Director Strategy and Business Development for DSM Biomedical, said, "Bone adhesives have the potential to transform orthopedics and vastly improve patient outcomes; in full support of our Vision of solving the world's healthcare needs through sustainable science."
Paul Burke, Managing Partner for PBC Biomed, said, "PBC Biomed is celebrating our 10th year of partnering with companies large and small to deliver science-based innovations in the medical device, biologic and pharmaceutical sectors. This agreement with Royal DSM brings us closer to our joint goal of accelerating medical innovation and enhancing patient wellness in the orthopaedic space."